FTC order could ease biopharma competition
In Amgen’s consent order with the US Federal Trade Commission…
In Amgen’s consent order with the US Federal Trade Commission (FTC) addressing the intended acquisition of Horizon Therapeutics, once finalised, some requirements will be effective for 15 years.